《科学》 第392卷 第6801期 · 2026年5月28日 · 中文解读
埃博拉疫情考验灵活的治疗试验设计
Ebola outbreak puts nimble treatment trial designs to the test · K. Kupferschmidt
约 11 分钟News在小程序里点播,20 到 60 分钟做好
这篇讲什么
本文报道了在刚果民主共和国爆发的埃博拉疫情中,研究人员采用适应性随机临床试验设计来测试抗病毒药物和抗体,但面临后勤和信任等挑战。
原文开头
Updated strategies for studying antivirals and antibodies will face logistical challenges on the ground KAI KUPFERSCHMIDT I n 2015, Amanda Rojek, then a young physician who had just started work on her Ph.D. at the University of Oxford, was pulled away to respond to the largest Ebola outbreak the world has ever seen. She helped run a clinical trial in Sierra Leone called RAPIDE, part of a scramble to test potential treatments as the virus surged through West Africa. But researchers had little experience and no consensus on how to do this well. RAPIDE tested just one experimental Ebola treatment; there was no control group, and setting everything up took months. …
摘自《科学》(Science)第392卷 第6801期 · 2026年5月28日,K. Kupferschmidt。仅引用开头一小段供了解文章,版权归原刊所有,全文请阅读原刊。

微信扫码,在小程序里听完整版
不用登录先听一篇 · 或在微信搜索小程序 晨间信号